Particle Data Platform

FDA Reversal On NMN

40:5542:43 · 108s

Baran recounts the unusual FDA about-face that first recognized, then tried to revoke, and ultimately reinstated NMN’s status as a dietary supplement—framing it as a win for consumers over pharma and a catalyst for more research.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.